News 27 Mar 2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
News 29 Feb 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Success stories 12 Dic 2023 "LA NOSTRA PRIMA SCELTA È STATA E SARÀ SEMPRE LA SVIZZERA" M&K Global AG è una holding con sede a Berna che si occupa di strategie per l’integrazione dei servizi con droni, implementazione nel mondo r...
News 10 Gen 2024 Noor Biotech opts to establish location in Basel Noor Biotech has established a presence in Basel. The start-up, which is managed by its Saudi Arabian co-founder Nuha Alekhmini, is developing a ...
News 20 Dic 2023 Proteomedix and Blue Water Biotech jointly found Onconetix Proteomedix has been acquired by Blue Water Biotech, which is based in Cincinnati in the US State of Ohio. The two firms have now jointly founded...
News 18 Dic 2023 UPM Biomedicals chooses the Basel Area as European bridgehead UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes in nanofibrillar c...
News 13 Dic 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
Success stories 08 Dic 2023 “Our first choice was and will always be Switzerland" M&K Global AG is a Bern-based holding company focusing on strategies for drone service integration, real-world implementation and education. ...
News 27 Nov 2023 Boehringer Ingelheim acquires T3 Pharma Boehringer Ingelheim has acquired T3 Pharma, which is based in the Switzerland Innovation Park Basel Area, for an amount of up to 450 million Swi...
成功故事 12 Dic 2023 “无论是过去或未来,我们的首选永远是瑞士" M&K Global AG 是一家总部位于瑞士首都伯尔尼的控股公司,专注于无人机服务集成、现实世界行业应用和相关教育战略。瑞士的 M&K Global AG 在 3 年半的时间里,从一个人运营成长为18人的组织。
성공 사례 12 Dic 2023 “우리의 첫 번째 선택은 스위스였고 앞으로도 스위스가 될 것입니다." M&K Global AG는 베른에 본사를 둔 지주회사로 드론 서비스 통합 전략, 현실세계 구현 및 교육에 중점을 두고 있습니다. M&K Global AG는 스위스에서 3년 6개월 만에 1인 운영체제에서 18인이 근무하는 회사로 성장할 수 있었습니...
Novità 02 Giu 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
成功談 12 Dic 2023 「最初の選択肢はスイスでしたし、これからもスイスであり続けます」 M&K Global AGはドローンサービスの統合戦略、実社会への導入、教育に注力する、ベルンを拠点とするホールディングカンパニーです。M&K Global AGはスイスで3年半の間に、1人体制だった運営から18人の組織に成長を遂げました。
News 23 Ago 2023 Forty51 Ventures provides the financial backing to found Mysthera Therapeutics Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided 3.5 million US dol...
News 24 Lug 2023 House of Lab Science opens in The Valley Young food and biotech companies can occupy fully equipped and maintained labs in The Valley from March 2025. The owners of the former Maggi area...
News 24 Mag 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Headquarters 15 Giu 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
Innovation 11 Lug 2023 Locate Investors Discover how you can benefit from Switzerland's strong investor base and several accelerator programs to support the launch and growth of your li...